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Abstract
Background: There is evidence from existing literature that ambient air pollutant exposure in early childhood likely
plays an important role in asthma exacerbation and other respiratory symptoms, with greater effect among
asthmatic children. However, there is inconclusive evidence on the role of ambient air pollutant exposures in
relation to increasing asthma prevalence as well as asthma induction in children. At the population level, little is
known about the potential synergistic effects between pollen allergens and air pollutants since this type of
association poses challenges in uncontrolled real life settings. In particular, data from sub-Sahara Africa is scarce and
virtually absent among populations residing in informal residential settlements.
Methods/design: A prospective cohort study of 600 school children residing in four informal settlement areas with
varying potential ambient air pollutant exposure levels in the Western Cape in South Africa is carried-out. The study
has two follow-up periods of at least six-months apart including an embedded panel study in summer and winter.
The exposure assessment component models temporal and spatial variability of air quality in the four study areas
over the study duration using land-use regression modelling (LUR). Additionally, daily pollen levels (mould spores,
tree, grass and weed pollen) in the study areas are recorded. In the panel study asthma symptoms and serial peak
flow measurements is recorded three times daily to determine short-term serial airway changes in relation to
varying ambient air quality and pollen over 10-days during winter and summer. The health outcome component of
the cohort study include; the presence of asthma using a standardised ISAAC questionnaire, spirometry, fractional
exhaled nitric-oxide (FeNO) and the presence of atopy (Phadiatop).
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Discussion: This research applies state of the art exposure assessment approaches to characterize the effects of
ambient air pollutants on childhood respiratory health, with a specific focus on asthma and markers of airway
inflammation (FeNO) in South African informal settlement areas by considering also pollen counts and
meteorological factors. The study will generate crucial data on air pollution and asthma in low income settings in
sub-Sahara Africa that is lacking in the international literature.
Keywords: Ambient air pollution, Environmental pollution, Outdoor air pollution, Traffic-related pollutants, Pollens,
Childhood asthma, Respiratory morbidities, Allergic diseases, Lung function, Airway inflammation,
Background
Childhood asthma is the most common chronic disease
in children globally and ranks in the top 20 contributors
of global disability-adjusted life years (DALY) in all chil-
dren; and among the top 10 causes of DALY amongst 5–
14 year olds [1]. The global mortality rates of childhood
asthma is approximately 0.7 per 100,000 [2]. Asthma im-
pacts significantly on the quality of life of a child as it
can interfere with physical exercise, results in school ab-
senteeism as well as underperformance at school due to
sleep interruption. It is estimated that two-thirds of asth-
matic children suffer from a noticeable disability and ap-
proximately ten million school days are missed yearly
[3]. Instances of severe asthma in children leading to fre-
quent school absences might consequently affect the
child’s education and probably career choice later in life.
Furthermore, asthma in children creates a burden on the
family since caregivers often take time ‘off-work’ to cater
for sick children, hence a major cause of parental work
absenteeism. Limitation of social life due to lack of sleep
has been found in 50% of parents with asthmatic chil-
dren and negligence of other siblings as more time is de-
voted to the asthmatic child [4].
Among other reasons, the increasing outdoor air pol-
lution may also contribute to the increase in asthma
prevalence in developing countries [5]. Ambient air pol-
lution is a major environmental health concern globally
affecting the population in both highly industrialised and
developing countries. An estimated 23% of all deaths
and 24% of the global burden of disease can be attrib-
uted to environmental factors, with ambient air pollu-
tion (especially particulate matter) estimated to be
responsible for 3.2 million deaths per year (3.1% of glo-
bal total DALYs) [5, 6]. In 2016, the WHO estimated
that only about one in every ten people breathe clean
air, according to the WHO Air Quality Guidelines [7].
The WHO further reported 3.7 million premature
deaths in both urban and rural areas to be attributed to
air pollution, which is mainly due to small particulate
matter of 10 μm or less in diameter (PM10). Low-and
middle-income countries (LMIC), where air pollution
emissions from power-plants, traffic, open waste burning
and other combustion sources are very common,
account for about 88% of these deaths [7]. The WHO
estimated that a 15% reduction in ambient air pollution-
related deaths can be expected from reducing ambient
particulate matter from 70 to 20 μg/m3 [7]. Respiratory
diseases are the leading cause of death from ambient air
pollution, responsible for over half of the deaths re-
ported [7]. Of special concern is the effect of ambient air
pollution on children as their immune systems and lungs
are not fully developed with the onset of exposures in
early-life [8, 9]. Furthermore, children tend to spend
more time outdoors in parks and play grounds, and
likely to breathe a greater amount of air pollutant per
body weight compared to adults similarly exposed. Re-
cent studies have suggested that the development of
asthma, atopy and infant mortality is associated with air
pollution, particularly traffic-related pollution [10]. The
evidence for the extent to which air pollution affects
children’s respiratory health is inconclusive suggesting
much need for further investigation.
Various studies have demonstrated that exposure to
ambient air pollutants in early childhood plays an im-
portant role in the exacerbation of asthma and other re-
spiratory symptoms with greater effect amongst
asthmatic children [11–16]. Furthermore, studies have
demonstrated the association between ambient air pollu-
tion and lung function deficits and more recently on in-
creased FeNO in children [17–24]. It has been
postulated that continuous exposure to air pollutants,
particularly outdoors where children spend most of their
time, may exacerbate the impact of early childhood ex-
posures that lead to asthma and other respiratory symp-
toms expression. However, it should be noted that the
bulk of these evidence comes from regions outside sub-
Sahara Africa. Furthermore, there is inconclusive evi-
dence on the role of ambient air pollutant exposures in
relation with increasing asthma prevalence as well as
asthma induction in children [25, 26].
Although environmental and lifestyle factors appear to
drive the increasing susceptibility to developing allergic
diseases such as asthma, the increased susceptibility in
response to pollen allergen in population exposed to
high levels of pollution remain elusive. While the patho-
genesis of asthma and allergies have demonstrated a link
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between combined exposure to air pollutants and pol-
lens in in-vitro and animal studies, little is known about
their synergistic effect at the population level [27]. A
growing body of evidence has demonstrated a link be-
tween enhanced risk of atopic sensitization and exacer-
bation of symptoms due to the interaction between air
pollutants and airborne allergens [27–29]. Nevertheless,
more research is needed to clarify the mechanism by
which air pollutants and pollens induce airway changes
in exposed individuals. Some recent evidence have dem-
onstrated that pollen allergen can also induce non-
atopic reactions such as irritation and inflammation in
addition to allergic responses such as immunoglobulin
production [27]. However, very few epidemiological
studies have taken into account separating allergic and
non-allergic asthma and underlying mechanisms due to
the common inflammatory component present in both
mechanisms. To better evaluate the relative contribution
of the role air pollution in allergic and non-allergic
asthma, more research is needed since air pollution is
considered to be a major risk factor for non-allergic re-
spiratory diseases.
Most studies of the association between air pollution
and childhood asthma have been performed in industria-
lised settings. Given the multifactorial nature of these
diseases, the need for research is particularly eminent in
LMIC where patterns of co-exposure, co-morbidities
and susceptibility may largely differ from those in West-
ern countries. The WHO also recommended in the 2016
report on the effect of ambient air pollution [7] that
more epidemiological studies are needed to estimate the
long-term health effect of air pollution especially in
LMIC plagued with unacceptable levels of air pollution.
Further studies in developing countries are needed so as
to render comparison between South African and other
developing countries to findings reported from other
parts of the world, thereby contributing to the evidence
on the associations between air pollution and asthma in
children.
Methods/design
Aim & objectives
The aim of this prospective cohort study is to investigate
the association between ambient air pollution and co-
exposure to pollen with respiratory morbidities focusing
on asthma among children in the Western Cape, South
Africa.
The objectives are:
1. To determine the prevalence of asthma (defined by
asthma symptom score, presence of airway
obstruction on spirometry, and elevated FeNO) in
primary school children residing mainly in informal
settlement areas of the Western Cape with diverse
exposure to air pollutants and airborne pollen.
2. To characterize baseline exposures, temporal trends
and spatial distribution of ambient air pollutants and
relevant airborne pollen and their association with
meteorological parameters on their dispersion.
3. To examine the effect of air pollutants and pollen
levels on asthma outcomes controlling for potential
confounders and exploring the potential for effect
modification:
a) To examine the effect of daily variations in ambient
air pollutants and airborne pollen levels across
seasons on asthma outcomes (defined by respiratory
symptoms and changes in serial peak flow and FEV1
measurements) in a panel study of participating
children in the Western Cape.
b) To examine the exposure-outcome relationships (at
baseline and at the 12 month follow-up assessment)
between exposure to ambient air pollutants and air-
borne pollen with asthma outcomes (defined by
asthma symptom score, presence of airway obstruc-
tion on spirometry, and elevated FeNO).
c) To explore longitudinal 12 month change in
ambient air pollutants and airborne pollen on
changes in asthma symptom score, lung function
(FEV1 and FEV1/FVC ratio), and FeNO in this
cohort.
4. To examine whether increased baseline FeNO
predicts new onset asthma (defined by increasing
asthma symptom score or presence of new asthma
symptoms).
Study population and design
The study areas includes three areas identified in a needs
analysis conducted by the Western Cape Department of
Environmental Affairs and Development Planning
(DEA&DP) in 2013. The prioritised areas include an
urban industrialised area in Cape Town (Milnerton/Mil-
nerton Ridge including Marconi-Beam, Phoenix and Joe
Slovo), a peri-urban area outside Cape Town with a large
informal sector (Khayelitsha) and a rural area (Oudts-
hoorn) more than 400 km outside Cape Town. Addition-
ally, an area (Masiphumulele, Noordhoek) with
negligible ambient air pollutants exposure and commu-
nity of similar socio-economic status as the prioritised
areas is identified. These four study areas are selected to
maximize contrasts in exposure levels to the different
ambient air pollutants.
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The study comprises of a baseline study and a 12-
months follow-up study of the cohort in which all exam-
inations including a child and caregiver questionnaire,
lung function testing in the form of spirometry, exhaled
nitric-oxide and allergy testing will be conducted. Add-
itionally, a panel study is embedded investigating sea-
sonal relationships between short-term variation in
ambient air pollution and lung function measured
through daily peak flow measurements in children dur-
ing a 2-week period in summer and winter. This ensures
a design whereby the exposures, potential confounding
factors and health outcomes are monitored seasonally
and repeatedly in a prospective manner.
Sampling
In total 600 participants are selected from children at-
tending primary schools located in the three prioritised
and one less-exposed areas. A list of all schools in the
study area is obtained from the Department of Educa-
tion in the Western Cape Province. One or two schools
from each area located nearest to the City of Cape Town
metro air quality monitoring stations are selected. One
hundred and fifty Grade-4 students in each study area
are targeted. Grade-4 students are selected for the study
since they will not leave primary school to enter senior
school during the study period. The average age of
Grade-4 students is 10 years; as such they are old
enough to adhere to instructions during the various tests
and reasonably confident to answer simple questions re-
garding their symptoms. This age group also provides a
key phase in the onset of childhood asthma which often
is preceded by atopic dermatitis and allergic rhinitis
(with reference to the ‘atopic march’). Although, there
are gender differences in asthma reported in the litera-
ture, all eligible Grade-4 students are included in the
study and gender will be adjusted-for, stratified and
assessed for interaction in the analyses.
After meeting the school principal, obtaining permis-
sion from the schools board, and obtaining the Grade-4
class lists and addresses, the houses of the school chil-
dren are visited by trained field staff to obtain the care-
givers (parent or guardian) consent. Random sampling is
used to select 75 students from the list of consented
children when the number of consented children ex-
ceeds 75 in each school.
All Grade-4 students attending selected schools qualify
for inclusion in the study. Baseline data is collected be-
tween February 2015 and August 2015, while the follow-
up data is obtained from May 2016 to September 2016.
However, spirometry is rescheduled for participants with
a positive response obtained from a pre-test question-
naire to any of the following items: If the child had a re-
cent operation (in last 12 months); If the child feels like
vomiting or has any pain; If the child is being treated for
Tuberculosis; If the child had flu, sinusitis or lung infec-
tion in the last 3 weeks. However, children with positive
response to ‘having epilepsy’ are excluded from doing
spirometry.
Questionnaire
Trained interviewers administered questionnaires to
child participants and their caregivers in their spoken
language in the cohort study. The use of mobile technol-
ogy is implemented in the administration and capture of
questionnaires. For interviews of child participants, the
questionnaire contains items on demographic factors
and respiratory health incorporating the standardized
and validated International Study of Asthma and Aller-
gies in Childhood (ISAAC) questionnaire [30]. For inter-
view of caregiver, the questionnaire contains items on:
i) Demographic factors (age, gender, education) of
child
ii) Birth history (Mother’s age at child’s birth,
birthweight, maternal smoking during pregnancy)
iii)Diet (child’s nutritional habit)
iv)Health impairment (presence of other illness and
vaccination profile)
v) Respiratory conditions and allergy (presence of
respiratory symptoms such as cough, wheeze,
shortness of breath and chest tightness, including
other allergic conditions such as eczema, itch/rash,
food allergy, pet allergy)
vi) School attendance (school absenteeism to assess the
impact of respiratory illnesses such as asthma)
vii) Asthma severity (doctor-diagnosed asthma and
other allergic diseases, presence of current wheeze)
viii) Health services utilization (regular hospital visits)
ix)Asthma medication
x) Exposure to indoor pollution and allergens (such as
heating and cooking fuels, dust mites, cockroaches,
rats, molds and pets)
xi)Household characteristics and hazards
xii) Respiratory health of the child based on the ISAAC
questionnaire (assessing the presence of
rhinoconjuctivitis) [30]
xiii)Child residential history to assess the duration of
exposure in the sampling study area
The questionnaires are translated and back-translated.
The questionnaires is administered at all phases of the
study.
Pulmonary function assessment
Pulmonary function assessments for the cohort study
are conducted during school visits, comprising spirom-
etry conducted according to the American Thoracic So-
ciety (ATS) guidelines [31] and fractional-exhaled nitric
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oxide measurement (FeNO). Spirometry and FeNO is
conducted at baseline and in the follow-up period. Add-
itionally, two intensive phases (once during peak winter
and another during peak summer) of serial peak flow
measurements are conducted bihourly per day during
the school time over a two week period for all school
child participants (panel study). During this period,
school children are asked to complete a bihourly symp-
tom activity log recording symptoms, odour, location
and activity. The serial peak-flow measurement is con-
ducted simultaneously at all schools.
Spirometry
An experienced technologist conducts spirometry using
a flow-volume spirometer (EasyOne 2001–3 Spirom-
eter). Spirometers are calibrated at least twice a day
using a three-litre syringe. The temperature and humid-
ity are monitored on a daily basis. The technologist is
blinded to the exposure status of participants. Spirom-
etry is performed in a sitting position with nose clips.
Each child participant performs a maximum of up to
eight trials to produce three acceptable curves. Test re-
producibility is used as a guide to whether further at-
tempts will be necessary. Reproducibility criteria is
based on the two best tracings for both FEV1 and FVC
varying by no more than 150 ml or 5%, whichever is
greater. However, failure to meet reproducibility criteria
does not result in exclusion of the spirogram results
from the statistical analysis. Poor reproducibility may
also be an independent marker of airway dysfunction
[32]. The lung function indices of primary interest in-
clude forced vital capacity (FVC) and forced expiratory
volume in one-second (FEV1). The best FEV1 and FVC
is used regardless of whether they belong to the same
tracing. Lung volumes obtained by spirometry are ad-
justed for body temperature and pressure according to
the temperature and atmospheric pressure measured on
a continuous basis throughout the day. Special instruc-
tions are given to participants to ensure that tested indi-
viduals do not take any anti-asthmatic inhalers (12 h
before) or oral asthma medications (48 h before) prior to
the test. Participants are administered an inhaled bron-
chodilator and have spirometry repeated after a mini-
mum of 10-min waiting period. Special precautionary
measures include having readily available oxygen and
B2-adrenergic agents for nebulization. Additionally,
emergency medical personnel are on-site or within quick
access at all times during the tests. All participating chil-
dren are assessed during school hours.
Fractional exhaled nitric oxide (FeNO)
Fractional-exhaled nitric oxide (FeNO) measurement is
a recognized non-invasive method for assessing allergic
airway inflammation [33]. The Fractional-exhaled nitric
oxide (FeNO) testing is conducted by a trained nurse. A
hand-held portable nitric oxide sampling device (NIOX
MINO® Airway Inflammation Monitor; Aerocrine AB,
Solna, Sweden) is used. The child is advised to sit com-
fortably and breathe normally for about five minutes to
acclimatize, and thereafter instructed to inhale close to
total lung capacity (TLC). This is followed by an imme-
diate exhalation at a constant flow rate of 50 ml/s for at
least four seconds. Two technically adequate measure-
ments are performed (at least 30-s interval) in line with
the American Thoracic Society/European Respiratory
Society recommendations [34]. The average value of the
two measurements is used in the analysis. Special in-
structions are provided to participants to ensure that
tested individual avoids strenuous exercise, eat nor drink
(at least an hour) prior to the test. The passive smoking
history and date of last medication of bronchodilator is
recorded. It is important to note that spirometric ma-
noeuvres may reduce exhaled NO levels; hence FeNO
measurements are done before spirometry. Furthermore,
children with upper and lower respiratory tract infection
have their measurements deferred until recovery or had
their measurement taken with infection state recorded.
The participants’ height and weight is measured and this
information is used to compute the body mass index
(BMI). Ambient NO and temperature are also recorded.
Panel study: Collection of bihourly symptoms log and peak
flow data
In the panel study, each child is asked to perform serial
peak flow measurements bihourly (just before school
starts, during the 1st break and 2 h thereafter) and
complete an activity symptoms log in between serial
peak flow measurements on each school day over each
of the 2-week sampling phases (summer and winter
phases). The activities recorded in the symptoms log in-
clude symptoms, odour detection and information about
location during the previous 2 h. Three consecutive ma-
noeuvres of peak expiratory flows are performed by each
child immediately prior to completion of the bihourly
logs using an individual Microlife Peak flow meter
(Microlife PF100). Each child is trained to use the device
before fieldwork starts and reminded daily during both
phases by trained research assistants. The Microlife
PF100 meets the ATS standards, and it is easy to use on
children due to its user-friendly interface. The device
measures both Peak Expiratory Flow (PEF) and FEV1.
This procedure is largely dependent on the child’s co-
operation, efforts and ability to inhale maximally. To ob-
tain a maximum value for the PEF with a rapid
upstroke, the children are encouraged to blow vigorously
as they physically can. To avoid measurement errors, the
children are advised to blow out quickly, and avoid flex-
ing the neck, as this might lead to the PEF dropping by
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10% due to visco-elastic properties of the trachea [35].
Testing are conducted simultaneously at all schools ac-
cording to the American Thoracic Society/European Re-
spiratory Society (ATS/ERS) guidelines. Trained research
assistants are present at each school at all times to over-
see the measurements.
Assessment of allergic status
Allergy tests: Phadiatop levels
Samples of blood (9 ml) are drawn from each participant
using a Becton Dickinson Vacutainer SST tube (with gel
medium and clot activator) by the nurse. Each sample is
labelled and stored in a cooler box at 4-degrees Celsius
before being transported to the laboratory for spinning
down. The blood is allowed to clot for 1–2 h at room
temperature (20–24 degrees Celsius) and then centrifuged
at 1350 rpm for 10-min at room temperature. The serum
is then transferred to another tube and stored at −20-de-
grees Celsius in a freezer. These serum samples are then
transferred to the main freezers where they are stored at
−80-degrees Celsius. The samples are then couriered to
the SANAS accredited (ISO 15189:2007), National Insti-
tute for Occupational Health (NIOH) Immunology la-
boratory for immunological analysis. Presence of
sensitization to common aeroallergens (house dust mites,
grass pollens, cat, dog, and cockroach) are determined by
the Phadiatop® test (Phadia AB, Uppsala, Sweden). The
analysis is done blinded to further details of the partici-
pant. The Phadiatop test is conducted in the baseline
study as well as in the follow-up period. A positive result
would be indicative of the presence of atopy.
Exposure characterisation
Ambient air pollutants
Exposure to ambient air pollution is estimated from a)
geographic information system-based indicators b) air
monitoring data from the stationary monitors in each of
the study areas, c) available dispersion and chemical
modelling, d) fine-scale land-use regression modelling
based on two air pollution measurement campaigns in
winter and summer in each study area at a total of 130
homes of study participants.
a) Geographic information system (GIS)-based
measures: GIS-based indicators are extracted as an
exposure proxy for point and mobile sources of air
pollution such as traffic-related pollutant (NO2 and
PM2.5). The distance of each participants’ address to
point sources, local and major roads, highways is
computed using ArcGIS software. In addition, sev-
eral buffers (50 m, 150 m and 200 m) are created
around each participant’s address, and the total
roadway length is calculated using ArcGIS. It should
be noted that roadway length within each buffer can
also be weighted-by the average traffic frequency
and vehicular types plying each roadway (depending
on data availability). Additionally, other GIS data
may also be used such as land use/classification,
street network, building and population density
which would also be calculated for different buffer
sizes.
b) Fixed-site air monitoring data: Ambient air
sulphur dioxide (SO2), nitrogen dioxide (NO2),
Particulate Matter of 2.5 μm in diameter (PM2.5),
Particulate matter of 10 μm in diameter (PM10), and
ozone (O3) measurements from the City of Cape
Town’s and DEA&DP stationary air quality
monitoring stations in each study area are obtained
throughout the study period. The sampled air
quality data are stored in the City of Cape Town’s
Data Acquisition System (DAS). The storing, pre-
validation and transmission of data on the Air Qual-
ity Monitoring Network is the responsibility of the
Western Cape Department of Environmental Affairs
and Development Planning. Most pollutants are
measured at seconds-to-minutes resolution using the
US Environmental Protection Agency (EPA) ap-
proved methods and the values are expressed as
one-hour averages.
c) Dispersion and chemical modelling: Dispersion
and chemical modelling is used to estimate air
pollution levels over specific time periods across the
different study areas. Input data for these models are
emissions from major sources such as industry,
household or domestic fuel-use obtained from
household surveys, traffic estimated from the num-
ber and types of vehicles in the areas, biomass fuel
burning and meteorological variables (such as wind
speed, wind direction, temperature, humidity, and
precipitation). High resolution distribution of pri-
mary pollutants concentrations is provided by the
dispersion modelling, while concentrations of sec-
ondary pollutants such as ozone and particulates are
derived from the chemical modelling. CALPUFF sys-
tem is used to create the dispersion modelling at a
resolution of 300 m over the study areas [36]. This
system captures complex terrain and diurnal wind
regimes such as land-sea breezes more effectively.
The model is based on the principle that meteoro-
logical factors influences the direction and dispersion
of pollutants from their point sources, and thus resi-
dential exposure depends on their location upwind
versus downwind of the point sources. On the other
hand, chemical modelling is used to model pollutant
transformation in addition to secondary formation of
aerosols which may impact on the concentrations of
PM2.5 in the Province. A comprehensive Air Quality
Model with Extensions (CAMx) is used to model
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chemical pollutants due to its suitability for the inte-
grated assessment of particulate and gaseous air pol-
lution over many temporal scales. The data from the
model is used to estimate the average exposures at
each participant’s residence in the short-, medium-,
and long-term through the study period (daily,
weekly, monthly and annually). These model output
are however highly dependent on the quality of their
input emission data.
d) Land-use regression (LUR) modelling: To refine
the spatial resolution of exposures at the individual
level, Land Use Regression (LUR) models are used to
estimate the spatial distribution of air pollutant
concentrations across each study area and for all
relevant locations. This is based on ambient air
pollutant measurements in all four study areas using
passive diffusion samplers to measure NO2, SO2 and
O3 and active pump-based 37 mm filter samples
(PM2.5, PM2.5 absorbance). In addition, real-time
continuous air pollutant measurements (NO2, O3,
CO, PM10, PM2.5, and PM1.0) is recorded at the
schools and reference site per study area. In three
study areas, 40 houses per study area including par-
ticipating schools and a background reference site
are selected to represent the full range of exposure
levels within the study area. However, for the
Noordhoek study area, a total of 20 houses is se-
lected due to its small geographical size. Measure-
ments in each selected house are conducted for a
week, over a 4-week sampling period per area, while
measurements at schools and the reference site are
done weekly throughout the entire 4-week sampling
period. GIS-based model predictors are derived from
ArcGIS software described above. Temporal adjust-
ment within each and across both seasonal measure-
ment campaigns (summer and winter) are done by
using data from schools, reference sites and from
the City of Cape Town’s and DEA&DP air quality
monitoring stations including meteorological data
from the South African Weather Service (SAWS).
Additionally, questionnaire responses on ambient
and indoor air pollution (such as heating and cook-
ing fuels), including dust mites, pets, moulds and use
of pesticides at home are considered in the exposure
assessment.
Pollen measurements
Tree pollen, grass pollen, weed pollen and mould spores
are measured in all the four study areas from July 2015
to March 2017, using the Burkard 7-day recording volu-
metric Spore Trap which allows for continuous spore
trapping. There are varying concentrations of pollen and
spore at heights above ground level, thus the trap is
placed above the ground level (ideally a flat rooftop) at a
minimum height of 1.5 m to avoid dust contamination.
Pollen and fungal spores are measured at each study
area for one-calendar year in order to properly assess
the seasonal peaks of the local aeroallergens. The aver-
age daily concentration is expressed as particles/m3
using the concentration conversion below;
N total area of strip 48mm 14mmð Þ
Area of stip analysed field diameter length of traverse x no of traverses x 14:4ð Þ
Where N = the pollen or fungal spore concentra-
tion per m−3.
14.4 = volume of air sampled per 24 h period, at
10−1 l/min.
Field diameter = width of microscope field.
Meteorological factors
Meteorological factors such as rainfall, sunshine,
temperature, barometric pressure, humidity, wind speed
and wind direction are obtained (minimum, maximum
and daily averages) from the South African Weather Ser-
vice (SAWS). These factors are considered in the LUR
models as well as in the statistical analyses of the associ-
ations between ambient air pollutants and respiratory
health outcomes in children. These factors have been
found to influence the spatial and temporal distribution,
deposition and formation (in the case of secondary pol-
lutant such as ozone), of pollutants including the altered
spatial and temporal distribution of allergens (pollens,
moulds and house dust mite) [27, 37]. Meteorological
factors have also been shown to influence the exacerba-
tion of allergic respiratory conditions including asthma
especially in vulnerable groups such as children [27].
Statistical analysis
Sample size calculation
The sample size required for the study was calculated
using the following formula below;
N≈4P 1‐Pð Þ Zα=2 þ Zβ
 
RDð Þ2
Where N = sample size, Zα/2 is the alpha risk, and Zβ is
the power
P ¼ P0 þ P1
2
P0, the prevalence of asthma is urban areas of Cape
Town estimated at 34.4% [38].
P1, the prevalence of asthma amongst exposed school
children, 48.8% found in a study conducted in Durban,
South Africa [39].
Therefore P¼0:344þ0:488¼0:4162 .
RD is the risk difference P1 – P0 = 0.488–0.344 = 0.144.
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Using an alpha risk of 0.05 and a power of 80%
(β = 0.20).
Thus, N≈4 0:416ð Þ 1‐0:416ð Þ 1:96þ0:842ð Þ
0:144ð Þ2 ¼ 368
The approximate sample size calculated for the study
is therefore 368.
Outcome variables
Doctor-diagnosed asthma
A positive response by the parent or guardian to the
question in the questionnaire, ‘if the child participant
was previously diagnosed by a doctor to have asthma’
and treated as a dichotomous variable (Yes, No).
Asthma symptoms scores
The operational definition of asthma based on asthma
symptoms will be a sum of positive answers to eight
main asthma symptoms and bronchial hyper-
responsiveness questions from the Child Caregiver ques-
tion, which generates a continuous asthma score ranging
from 0 to 8 [40]. Continuous asthma scores will be pro-
duced from the following questions below;
1. How many episodes of wheezing or whistling has
the child had in the past 12 months?
2. In the past 12 months, how many times has the
child had wheezing that made it hard for him or her
to breathe or catch his or her breath?
3. In the past 12 months, how many times has the child
complained that his or her chest felt tight or heavy?
4. Does the child get short of breath walking with
other children of his/her own age on level ground?
5. In the past 12 months, how many times has the
child coughed with exercise or running or playing
hard?
6. In the past 12 months, how many times has the
child’s sleep been disturbed due to wheezing,
coughing, chest tightness or shortness of breath?
7. Has a doctor or nurse ever told you that the child
has asthma?
8. Has the child ever taken any medication for asthma?
Airway obstruction
Airway obstruction will be defined as a reduced FEV1
(less than 80% of the predicted value- using the multi-
ethnic reference values for spirometry for the 3–95 year
age range [41]) and a reduced FEV1/FVC ratio (less than
0.8) recorded as a dichotomous variable (Yes, No).
Airway inflammation
Airway inflammation will be assessed using the frac-
tional exhaled nitric oxide (FeNO) levels, which is a
marker of eosinophilic airway inflammation. Elevated
levels of FeNO have been implicated in the detection of
subclinical airway inflammation, even in the absence of
lung function impairment and absence of asthma symp-
toms [42]. Children with FeNO levels less than 15 ppb
will be considered normal; those with levels between 15
and 35 ppb will be categorized as ‘elevated’, while chil-
dren with FeNO levels above 35 ppb will be categorized
as having ‘high’ levels [42].
Atopy
Atopy will be defined as individuals with serum Immu-
noglobulins E (IgE) antibodies above 0.35kUA/l on the
Phadiatop test. Although this measurement does not
provide information on the specific allergens the individ-
ual is sensitized-to, it does give an indication of the pres-
ence of an allergic sensitization to common inhalant
allergens. Serum IgE levels are also linked to airway
hyper-responsiveness in the presence or absence of
asthma symptoms [38].
Variability in PEF and FEV1
Increased intraday variability and lower nadir values
(minimum best or daily lowest valid values) are markers
of worsening of asthma. Thus, the average within-day
variability in PEF and FEV1 over the 10-days in each
sampling season (summer and winter) will be calculated
for each participant including the average minimum best
values of PEF and FEV1 over the 10-days.
Rapid decliners in FEV1
This will be used as another marker of airway obstruction
and defined as children whose FEV1 reduces by 30 ml/year
(the upper limit of physiological decline) and/or children
with deficit in lung function growth. The deviation from
the normal lung function growth curve will also be ex-
plored using the multi-ethnic reference values for spirom-
etry for the 3–95 year age range [41].
New-onset asthma
A new asthma case will be defined as a child with no
prior parental report of a physician diagnosis of asthma
in the baseline survey whose parent or guardian reports
a doctor diagnosis of asthma in the follow-up year. Add-
itionally, participants defined as rapid decliners in FEV1
on follow-up and/or participants with appreciable
changes in the asthma symptom score will also be classi-
fied as new asthma cases.
Statistical analysis protocol
Analysis protocol for objectives 1
Descriptive analyses is used to examine the characteris-
tics of the study population, to characterize the asthma
symptom score (ASS), the distribution of the various
pulmonary function tests (PFT), and FeNO measure-
ments during year-1. The ASS is based on the sum of
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positive answers to eight main asthma symptoms and
bronchial hyper-responsiveness questions, while airway
obstruction and airway inflammation is based on defini-
tions previously described. Univariate linear, logistic,
Poisson or ordered logistic regression analyses will be
used to examine the association between variables, in-
cluding demographic characteristics, personal character-
istics, and household characteristics with respiratory
outcomes including allergic status, ASS, spirometric in-
dices and FeNO.
Analysis protocol for objectives 2
The mean annual levels and seasonal variations, annual
and seasonal exceedances of South African Ambient Air
Quality Standards and annual maximum levels in NO2,
SO2, PM, and O3 in each area will be determined from
continuous data from ambient air quality monitoring
stations during the study period and also dispersion
modelling data. Annual and seasonal averages of NO2,
SO2 and PM, will be determined from average 24-h
levels, while for O3, an eight-hour daytime average (from
10 a.m. to 6 p.m.) and of the one-hour maximal levels
will be computed. Missing data (e.g. from technical fail-
ures) in ambient air quality monitoring data will be im-
puted based on regression models using measurement
data from other close monitoring sites and meteoro-
logical variables. Furthermore, spatial variation in pollut-
ants in each area will be determined using LUR as
described above. The LUR models constructed for the
time period of the measurement campaigns will be ex-
trapolated to other time windows including long-term
averages by using data measurements from the station-
ary air quality monitoring stations within each area as
well as meteorological data.
The total airborne pollen measured in all four study
areas will be described as a continuous variable and later
categorize as follows; Tree pollen in count/m3 ranging
from 0 to 15 ‘low’, 16–90 ‘moderate’, 91–1500 ‘high’ and
above 1500 ‘very high’; Grass pollen in count/m3 ranging
from 0 to 5 ‘low’, 6–20 ‘moderate’, 21–200 ‘high’ and
above 200 ‘very high’; Weed pollen in count/m3 ranging
from 0 to 10 ‘low’, 10–50 ‘moderate’, 51–500 ‘high’ and
above 500 ‘very high’; and mould spores in count/m3
ranging from 0 to 900 ‘low’, 900–2500 ‘moderate’, 2500–
25,000 ‘high’ and above 25,000 ‘very high’. Time-series
analysis will be used to investigate the seasonality of each
airborne pollen count while their correlation between me-
teorological variables such as temperature, relative humid-
ity, rainfall and wind speed and direction two to 3 days
before measured levels will also be explored.
Analysis protocol for objectives 3
i) Protocol for objectives 3a.
Exposures: In the panel study, the hourly and daily av-
erages of each pollutants (24-h averages for PM, SO2
and NO2, and 8-h average for O3) and airborne pollens
will be determined for the same day as well as for a lag
period of 7-days.
Outcomes: Daily nadir (minimum best) and intraday
variability of peak expiratory flow (PEF) and FEV1 will
be used as markers for the worsening of asthma.
Covariates: The potential confounders determined
apriori include: age, gender, race/ethnicity, asthma medi-
cation use, respiratory allergy history, atopic status, BMI,
hour and day (of the week) of PEF, season, and
temperature. Other covariates with P-value < 0.20 from
the bivariate analysis will also be included in the multi-
variate model.
Analytical method: A general additive multiple linear
regression model (GAM) will be fitted for predicting the
percent change in within day PEF and FEV1, and nadir
PEF and FEV1 for an interquartile range (IQR) increase
in particular pollutant and airborne pollen while taking
into consideration possible confounders and effect modi-
fiers including penalized splines for seasonal and me-
teorological variations. The IQR scaling will enable the
percentages to be directly relevant to the exposure expe-
rienced by the participants and will also make the per-
centages for different pollutants directly comparable to
each other. To account for within-subject correlation,
Generalized Estimating Equation (GEE) regression
model will also be used as it focuses on estimating the
average response through the fixed-effect or random-
effect, as opposed to a regression parameters that pre-
dicts the effect of changing one or more covariates on a
given participant.
ii) Protocol for objectives 3b.
Exposures: The hourly and daily averages of each pol-
lutants (24-h averages for PM, SO2 and NO2, and 8-h
average for O3) and airborne pollens will be used to con-
struct a lag of up to 30 days. The annual averages of air
pollutants from the LUR will also be considered.
Outcomes: Asthma symptom score (ASS) will be on an
ordinal scale ranging from 0 to 8 as defined above. Air-
way obstruction will be defined as a dichotomous vari-
able with reduced FEV1 (less than 80% of the predicted
value) and a reduced FEV1/FVC ratio (less than 0.8).
Airway inflammation will be assessed using the log-
transformed FeNO levels on a continuous scale and also
as a polychotomous (ordered) variable as categorized
above.
Covariates: The potential confounders include; age,
gender, race/ethnicity, asthma medication use, respira-
tory allergy history, atopic status, BMI, and day (of the
week) of test date, season, and temperature. Other co-
variates with P-value < 0.20 from the bivariate analysis
will also be included in the multivariate model.
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Analytical method: Multiple linear regression will be
used to model the associations between IQR range in-
crease (or a 10 μg/m3 increase where applicable) in pol-
lutants (air pollutants and airborne pollen) and
continuous outcome of interest while taking into consid-
eration possible confounders and effect modifiers. Mul-
tiple logistic regression will be used in the case of a
binary outcome while multiple ordinal regression will be
used for ordinal outcomes such as ASS. In addition, to
examine the co-dependency of the various pollutants,
the correlation structure will be used to guide the selec-
tion of a two-pollutant model to avoid potential multi-
collinearity. Sensitivity analysis on the lag structure will
also be done using different exposure windows up to
60 days prior to examinations, whenever appropriate, to
evaluate the temporality of possible effects. For the pur-
pose of this analysis, long-term effects of pollution levels
will be investigated as potential confounders or effect
modifiers of the short-term effects in models that will
include random intercepts.
iii) Protocol for objectives 3c.
Exposure: The change in annual averages of 24-h
period for NO2, SO2 and PM, and 8-h daytime average
for O3, including airborne pollen levels across the cohort
study period.
Outcomes: Changes in ASS at follow-up, changes in
levels of FeNO (ΔFeNO) or percentage predicted FEV1
(Δ%FEV1) and FEV1/FVC ratio (ΔFEV1/FVC) between
the two study periods.
Covariates: The potential confounders include; age,
gender, race/ethnicity, asthma medication use, respira-
tory allergy history, atopic status, BMI, hour and day (of
the week) of test, season, and temperature. Adjustment
for short-term effects of air pollution using appropriate
lag structure at each study period together with potential
confounders and effect modifiers taken into consider-
ation, will help assess the independent effects of long-
term air pollution. Time independent covariates (ΔZ)
such as race/ethnicity effects will be assessed together
with time-elapsed between the two child-specific yearly
test dates (ΔAge), while time-varying covariates (ΔW) ef-
fects will be assessed considering all possible transitions
or changes over time for categorical and continuous co-
variates respectively. The most appropriate linear distrib-
uted lag models will be chosen from all possible types of
lag-based models for short-term effects of air pollution,
and the model selection will be based on the Akaike In-
formation Criterion (AIC). The confounding effect of
ambient temperature will be tested using the lag
structure selected for the short-term air pollutant ef-
fects. Potential effect modifiers such as gender,
asthma status, respiratory allergy, baseline outcome
status (obstruction status, FeNO levels) and season
will be tested in the final model.
Analytical method: Two strategies will be employed in
these analyses. The first is a cohort analysis starting with
a disease-free cohort to explore new-onset of asthma,
while the second will be a change-analysis to investigate
the changes in the respiratory outcomes over time. To
explore the association between the asthma score and
pollutant concentrations both defined at follow-up, in a
subpopulation reporting neither symptoms nor asthma
at baseline, a negative binomial regression model (with a
log link) will be used to account for extra-Poisson vari-
ation due to the distribution of the asthma score, with a
majority of zeros. The result will be expressed as ratios
of the mean asthma scores (RMS). The pollutants effect
will be scaled for an increase of 10 μg/m3 higher concen-
tration. The subpopulation of interest will be considered
a sample being in all likelihood free of asthma at base-
line. Thus, new onset of symptoms (a reflection of
asthma incidence) might be interpreted following the oc-
currence of symptoms at follow-up. To account for the
participant reporting only one of the symptoms at follow-
up, further analysis will be performed by comparing those
with none or only one symptoms (coded as participants
free of symptoms) at follow-up with those with at least
two symptoms. This will also be followed-up by consider-
ing those reporting none, one or two symptoms as partici-
pants free of symptoms, comparing them with
participants reporting at least three symptoms.
Multiple linear regression will be used to assess the re-
lationship between changes in levels of FeNO (ΔFeNO)
or percentage predicted FEV1 (Δ%FEV1) and FEV1/FVC
ratio (ΔFEV1/FVC) between the two study periods and
the corresponding changes in ‘long term’ and ‘short
term’ air pollution and airborne pollen levels. A 12-
month period prior to the day of tests will be used to as-
sess the effects of changes in long term pollution levels,
while adjusting for short term levels based on lags of up
to 60 days prior to the day of tests. The model will as-
sume a general form provided below;
ΔFeNO Δ%FEV1 or ΔFEV1=FVCð Þ
¼ β0ΔAgeþ β1ΔAPLT þ β2ΔAPST
þβ3ΔPLT þ β4ΔPST þ β5ΔTempST
þγTZ x ΔAge þ γTΔW þ ε
where ΔAge, ΔAPLT, ΔAPST, ΔPLT, ΔPST, and ΔTempST de-
notes the time elapsed between the two tests, changes in
long-term air pollution levels, short-term pollution, changes
in long-term pollen levels, short-term pollen levels, and
temperature levels, respectively. The change-on-change
model will allow for exploring the determinants of change
in FeNO or %FEV1 or FEV1/FVC rather than determinants
of level of the actual FeNO or %FEV1 or FEV1/FVC. In an
attempt to explore the change in obstructive pattern
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defined by reduced FEV1 less than 80% of the predicted
value and a reduced FEV1/FVC ratio less than 0.8, a binary
variable will be created with participant changing from
non-obstructive airways to obstructive airways coded as 1;
those without change in obstructive airways pattern also
coded as 1; those with changes from obstructive airways to
non-obstructive airways coded as 0; and those without
change in non-obstructive airways pattern also coded as 0.
Thus, a multiple logistic regression will be used to model
the association between change in obstructive patterns and
change in exposure taking into consideration confounding
and effect modifiers.
Analysis protocol for objectives 4
Predictor: Baseline FeNO levels.
Outcome: Crude incidence rates for new-onset asthma
(defined by increasing ASS or presence of new asthma
symptom) will be calculated by dividing the number of
cases by the total person-years at risk. Follow-up is con-
sidered complete at the time of reported diagnosis for
children who developed new-onset asthma.
Covariates: The potential confounders include; age, gen-
der, race/ethnicity, asthma medication use, respiratory al-
lergy history, atopic status, BMI, season, temperature
including average ambient air pollution and airborne
pollen levels on the day of the FeNO measurement.
Analytical approach: To investigate the relationship
between baseline FeNO with new-onset asthma, incident
rates will be calculated while exploring series of multi-
variate modelling approaches to adjust for potential con-
founders and heterogeneity of effects within subgroups
of children. A cohort analyses starting with a disease-
free cohort will be fitted to investigate the association
between FeNO and new-onset asthma adjusting for pos-
sible confounders including lifetime history of wheezing.
Fitted models with appropriate interaction terms with
statistical significance tested by partial likelihood ratio
test will be used to assess heterogeneity of associations
among subgroups. Thereafter, stratified analyses will be
performed in the presence of such significant inter-
action. Splines and piecewise cubic polynomials joined
smoothly at a number of breakpoints (knots) will be
used to explore the nonlinearity nature of FeNO effects.
Discussion
This research intends to explore state of the art ap-
proaches in the characterization of exposure to ambient
air pollutant to investigate its effects on children’s re-
spiratory health (with a specific focus on asthma) in
South African informal settlement areas, a heavily under
researched setting. The research employs the application
of more novel outcomes and exposure measures such as
biological markers of airway inflammation (such as
FeNO) in addition to traditional measures (spirometry,
peak expiratory flow, asthma symptom score, and aller-
gic sensitization to common inhalants) as well as ambi-
ent air pollution estimates derived from LUR modelling
and GIS-based indicators in addition to dispersion mod-
elling and air quality monitoring stations data. Addition-
ally, the study measures pollen levels (mould spores,
tree, grass and weed pollen) in the study areas supple-
mented with meteorological factors (such as wind direc-
tion, wind speed, temperature, humidity, pressure and
sunshine) that may impact on pollutant levels and pollen
counts. This study attempts to investigate the synergistic
effect of air pollutant and pollen exposures on both
new-onset childhood asthma and asthma exacerbations
at the population level. Furthermore, this study promises
to provide additional data for the Western Cape Prov-
ince of South Africa to further explore the association
between ambient air pollution and respiratory morbidity
(childhood asthma) in South Africa. The study will gen-
erate crucial data on air pollution and asthma in low in-
come settings in sub-Sahara Africa that is lacking in the
international literature.
A demonstrable positive association between ambient air
pollution and asthma in children in the Western Cape
would support the importance and urgency of improving
ambient air quality in the Province and particularly in the
study areas. This would contribute towards highlighting the
need for ongoing ambient air quality monitoring and strat-
egies for the continued reduction of air pollutants from
likely sources such as traffic, passive smoking, industries,
and domestic fuels. There is potential to use these informa-
tion towards increasing and promoting asthma awareness
and asthma education in communities with a high preva-
lence of asthma including the study communities. It is be-
lieved that such public health promotion initiatives would
assist in reducing associated asthma morbidity. Education
programmes will emphasize the need for household envir-
onmental management including indoor dust control, own-
ership of certain pets, pest and bio-aerosol control,
prevention of smoking indoors and actively discouraging
adults from smoking particularly around children or in the
vicinity of their rest, recreational or study areas. These mea-
sures will, in conjunction with ambient air quality manage-
ment, result in an improved quality of life of asthmatics,
particularly those with persistent asthma including those
who are susceptible. Since air pollutants have been shown
to influence the allergenic content in plants by influencing
pollen production and allergenic protein in pollen grains,
abatement of air pollution will mitigate effects of climate
change, allergen exposures, air quality and health status of
vulnerable populations.
Furthermore, the findings from this project will also help
the Department of Environmental Affairs and Development
Planning (DEA&DP) in the Western Cape, South Africa to
develop regional and spatial plans that consider these
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findings (with regard to location of industries and major
roads close to residential areas), and review environmental
exposure standards. This will contribute towards highlight-
ing the importance of ongoing monitoring of air pollution
pollen exposures near urban areas and near schools, with
results communicated to the public in a concise and under-
standable means. This would contribute towards the pro-
tection of public health during periods of high levels of
ambient air pollution whereby authorities can use this in-
formation as part of their decision-making processes.
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